Highbridge Capital Management’s NeoGenomics NEO Stock Holding History

Highbridge Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-67,403	Closed	-$531K	–	1487
2017 Q1	$531K	Buy	+67,403	New	+$549K	0.01%	871
2016 Q1	–	Sell	-24,743	Closed	-$195K	–	1705
2015 Q4	$195K	Buy	+24,743	New	+$181K	﹤0.01%	1360

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Highbridge Capital Management's NEO Position: Q2 2017 in Review

Highbridge Capital Management sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 67,403 shares — an estimated $531K sold.

Highbridge Capital Management first reported a position in NEO in Q4 2015 and held it in 2 quarters. The position peaked at $531K in Q1 2017. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Highbridge Capital Management reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 67,403 NeoGenomics shares in Q2 2017, an estimated $531K.
Highbridge Capital Management first reported a position in NeoGenomics in Q4 2015 and held it in 2 quarters.
Highbridge Capital Management's NeoGenomics position peaked at $531K in Q1 2017.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.